Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1101820.RAYWMwUWYv-kCJ24hYUbeLR-le4W4ZStn6lPwQjxIofNE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1101820.RAYWMwUWYv-kCJ24hYUbeLR-le4W4ZStn6lPwQjxIofNE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1101820.RAYWMwUWYv-kCJ24hYUbeLR-le4W4ZStn6lPwQjxIofNE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1101820.RAYWMwUWYv-kCJ24hYUbeLR-le4W4ZStn6lPwQjxIofNE130_provenance.
- NP1101820.RAYWMwUWYv-kCJ24hYUbeLR-le4W4ZStn6lPwQjxIofNE130_assertion description "[The mTOR pathway is an important therapeutic target in vascular tumors, and topical mTOR inhibitors may provide an alternative and well-tolerated therapy for the treatment of cutaneous vascular lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1101820.RAYWMwUWYv-kCJ24hYUbeLR-le4W4ZStn6lPwQjxIofNE130_provenance.
- NP1101820.RAYWMwUWYv-kCJ24hYUbeLR-le4W4ZStn6lPwQjxIofNE130_assertion evidence source_evidence_literature NP1101820.RAYWMwUWYv-kCJ24hYUbeLR-le4W4ZStn6lPwQjxIofNE130_provenance.
- NP1101820.RAYWMwUWYv-kCJ24hYUbeLR-le4W4ZStn6lPwQjxIofNE130_assertion SIO_000772 23938603 NP1101820.RAYWMwUWYv-kCJ24hYUbeLR-le4W4ZStn6lPwQjxIofNE130_provenance.
- NP1101820.RAYWMwUWYv-kCJ24hYUbeLR-le4W4ZStn6lPwQjxIofNE130_assertion wasDerivedFrom befree-2016 NP1101820.RAYWMwUWYv-kCJ24hYUbeLR-le4W4ZStn6lPwQjxIofNE130_provenance.
- NP1101820.RAYWMwUWYv-kCJ24hYUbeLR-le4W4ZStn6lPwQjxIofNE130_assertion wasGeneratedBy ECO_0000203 NP1101820.RAYWMwUWYv-kCJ24hYUbeLR-le4W4ZStn6lPwQjxIofNE130_provenance.
- befree-2016 importedOn "2016-02-19" NP1101820.RAYWMwUWYv-kCJ24hYUbeLR-le4W4ZStn6lPwQjxIofNE130_provenance.